u0433u0430u0441u0442u0440u043eu0440u0435u0437u0438u0441u0442u0435u043du0442u043du044bu0435 oral pharmaceutical compositions comprising duloxetine or its u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable derivatives

摘要

the present invention relates to pharmaceutical compositions comprising an active core containing duloxetine or its u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable etc. u043eu0434u043du044bu0435, separation layera ph modifier, and u0433u0430u0441u0442u0440u043eu0440u0435u0437u0438u0441u0442u0435u043du0442u043du043eu0435 coating containing u0433u0430u0441u0442u0440u043eu0440u0435u0437u0438u0441u0442u0435u043du0442u043du044bu0439 polymer selected from the u0441u043eu043fu043eu043bu0438u043cu0435u0440u043eu0432 u043cu0435u0442u0430u043au0440u0438u043bu043eu0432u043eu0439 acid, and not necessarily the the upper layer cover.